Developer docs
API playgroundTry for free, no card

Search company profiles

Clongen Laboratories

Full company profile

uuid000beb7

Namestring
Clongen Laboratories
Legal namestring
Clongen Laboratories, LLC
Websiteurl
clongen.com
Company typeenum
Private
Founded yearint
1999
Descriptiontext

Clongen Laboratories, LLC is a privately held, founder-led specialty molecular diagnostics laboratory headquartered in Gaithersburg, Maryland. Founded in 1999 by Dr. Ahmed Kilani, the company operates a 6,000 square-foot CLIA-certified, CAP-accredited facility holding two FDA registrations and clinical laboratory licenses in Maryland, Rhode Island, Pennsylvania, and California. Its core technology is real-time and conventional PCR applied to detection of infectious agents, supplemented by proprietary methods including a Mycoplasma Multiplex PCR Detection Kit (MycoFind) and a pre-enrichment protocol for low-copy tick-borne pathogens such as Borrelia, Babesia, Bartonella, and Mycoplasma species.

The business is organized into three service lines: Clinical Diagnostics Services (240+ molecular assays for clinicians, hospitals, and reference clinical laboratories, with a specialty in tick-borne illness and Lyme disease), Contract Research Services (GLP-compliant lot release and FDA review studies, including sterility testing, LAL bacterial endotoxin testing, mycoplasma testing in biologicals, and clinical trial support for pharma and biotech), and Veterinary Diagnostic Services (100+ assays covering companion animals, livestock, primates, rodents, birds, amphibians, and reptiles). Pricing is quote-based with some published unit prices (e.g., MycoFind kit at $250, LAL GLP at $325 per sample, Mycoplasma PCR at $109 per sample); the company advertises pricing at least 10% below competitors and offers volume discounts.

The go-to-market is sales-led, relying on a direct team reaching clinicians, hospitals, and clinical labs primarily through the company website, PR Newswire releases, toll-free phone (877-CLONGEN), and quote forms. Distribution is exclusively direct; samples are shipped to the Gaithersburg lab. The company is unrelated in name to any other entity and is owned by its founder. A sister company, Clongen Pharma, LLC, is announced for launch in March 2026 to develop cancer therapeutics — a separate entity outside Clongen Laboratories' diagnostic scope. Clongen does not disclose revenue and has no external funding rounds on record.

Short descriptiontext

Clongen Laboratories is a CLIA-certified, CAP-accredited specialty molecular diagnostics lab in Gaithersburg, MD offering 240+ PCR-based tests for clinicians, hospitals, reference labs, biotech CROs, and veterinarians, with a specialty focus on tick-borne and other infectious diseases.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
1–10
akta.pro rankint
HeadquartersGaithersburg, United States
HQ citystring
Gaithersburg
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
molecular diagnostics services, contract research organization, clinical laboratory testing, PCR detection assays, veterinary diagnostic services
Industry2 codes
PRIMARYHLAGAAAE
Central Laboratory & Clinical Trial Testing CROs
SECONDARYHLAGADAC
Release Testing & Batch Certification (QC)
NAICS code2 codes
  • Medical Laboratories621511
  • In-Vitro Diagnostic Substance Manufacturing325413
SIC code2 codes
  • Services-Medical Laboratories8071
  • Services-Commercial Physical & Biological Research8731
Product category
Molecular Diagnostics / Clinical Laboratory Services
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model4 records
1Clinical Diagnostic Testing Services
TypeProfessional Services
Description

Molecular-based assays for detection of common pathogens (bacteria, viruses, fungi, and parasites) offered to clinicians, hospitals, and clinical laboratories. Includes tick testing, STD tests, bloodborne pathogen tests, and over 200 assays for infectious disease detection.

clongen.com
2Contract Research Services
TypeProfessional Services
Description

GLP-compliant studies required for lot release and FDA review for pharmaceutical companies, biotech firms, and research institutions. Includes sterility testing, LAL bacterial endotoxin testing, Mycoplasma testing in biologicals, and custom molecular and cell biology services.

clongen.com
3Veterinary Diagnostic Services
TypeProfessional Services
Description

Over 100 assays to identify diseases or cause of death in animals including dogs, cats, horses, livestock, primates, rodents, birds, amphibians, and reptiles.

clongen.com
4Test Kit Sales
TypeHardware Sales
Description

Sale of MycoFind Mycoplasma PCR Detection Kit (catalog number MF001, Version 1.0) priced at $250.00 per unit for 100 reactions. Ships with overnight ice packs.

clongen.com
Marketing channels4 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels1 record

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components6 values
Personnel, Operations, Technology or R&D, Infrastructure, Supply Chain, Marketing or Sales
Pricing details6 tiers
1MycoFind Mycoplasma PCR Detection Kit – $250.00
ModelUnit PricingBilling cadencePay-as-you-go
Notes

Catalog Number MF001, Version 1.0. Mycoplasma Multiplex PCR Detection Kit – $250.00. Shipping and handling in continental USA is $30 (Overnight on ice packs).

clongen.com
2Pre-Enrichment per organism – $125
ModelUnit PricingBilling cadencePay-as-you-go
Notes

Cost of $125 per organism in addition to running the PCR test. Covers Mycoplasma species, Bartonella species, Babesia species, and Borrelia species.

clongen.com
3LAL Endotoxin Testing GLP – $325 per sample
ModelUnit PricingBilling cadencePay-as-you-go
Notes

Protocol CB129, Turnaround Time: 2-5 Days. Price: $325 per sample (includes testing 6 sample concentrations in duplicates).

clongen.com
4LAL Endotoxin Testing Non-GLP – $225 per sample
ModelUnit PricingBilling cadencePay-as-you-go
Notes

Protocol CB130, Turnaround Time: 2-5 Days. Price: $225 per sample (includes testing 6 sample concentrations in duplicates).

clongen.com
5Mycoplasma Testing by Multiplex PCR (Non-GLP) – $109
ModelUnit PricingBilling cadencePay-as-you-go
Notes

Catalog Number 131, Turnaround Time: 1-3 days, Price: $109 per sample.

clongen.com
6Candida tropicalis – $200
ModelUnit PricingBilling cadencePay-as-you-go
Notes

Test code 1234, CPT Code 87798, Price: $200, Turnaround: 2-4 days.

clongen.com
GTM typeB2B
B2B
Offering typeServices
Services
Brand1 of 2 records shown
1MycoFind
Description

Mycoplasma Multiplex PCR Detection Kit - a test kit product line for detection of Mycoplasma, Acholeplasma and Ureaplasma species in cell cultures

clongen.com
+1 more record
Core offering1 text field

Clongen Laboratories is a CLIA-certified, CAP-accredited clinical molecular diagnostics laboratory that performs PCR-based testing for infectious agents in human and animal specimens. The company operates three service divisions: Clinical Diagnostics Services (200+ molecular assays), Contract Research Services (GLP-compliant lot release, sterility, LAL endotoxin, and mycoplasma testing for pharma/biotech), and Veterinary Diagnostic Services (100+ assays across many species), and also sells the MycoFind Mycoplasma PCR Detection Kit as a research product.

Differentiator
Functional benefit
Problem solved
Product overview1 text field

Clongen Laboratories is a molecular diagnostics laboratory offering three core divisions: Clinical Diagnostics Services, Contract Research Services, and Veterinary Diagnostic Services. The company provides more than 240 molecular-based PCR tests for detection of human pathogens (bacteria, viruses, fungi, parasites), with special expertise in tick-borne illnesses and Lyme disease. For contract research, the company offers GLP-compliant lot release testing including sterility testing, bacterial endotoxin testing (LAL), mycoplasma testing, and mycoplasma elimination services. The company also manufactures the MycoFind™ Mycoplasma PCR Detection Kit as a research use product. All services operate under CLIA certification and CAP accreditation with state licenses in multiple states.

Product and service11 records
1Clinical Diagnostics Services
CategoryClinical Diagnostics / Molecular Diagnostics
Description

CLIA-certified clinical laboratory offering more than 200 molecular-based PCR assays for detection of bacteria, viruses, fungi, and parasites, with specialty in tick-borne illnesses (including Lyme disease), STD testing, bloodborne pathogen testing, pulmonary disease testing, parasitology, mycology, and virology; serves clinicians, hospitals, and clinical laboratories submitting patient specimens.

2Contract Research Services
CategoryContract Research / GLP Testing Services
Description

FDA-compliant contract research organization providing GLP-compliant lot release testing, sterility testing, mycoplasma testing in biologicals per 21CFR 610.30 and 9CFR 113.28, LAL bacterial endotoxin testing, custom molecular and cell biology services, and clinical trial support for pharmaceutical, biotech, and research institution clients.

3Veterinary Diagnostic Services
CategoryVeterinary Diagnostics
Description

Veterinary diagnostic testing division offering more than 100 molecular assays to identify diseases or determine cause of death across a broad range of animal species including dogs, cats, horses, livestock, primates, rodents, birds, amphibians, and reptiles; serves veterinarians and animal health professionals.

4MycoFind™ Mycoplasma PCR Detection Kit
CategoryDiagnostic Test Kit (Research Use)
Description

Multiplex PCR detection kit (Catalog MF001, Version 1.0) for amplification of a conserved region of 16S ribosomal DNA of more than 25 Mycoplasma, Acholeplasma, and Ureaplasma species; sold as a research-use product with overnight ice-pack shipping (taq DNA polymerase supplied by user).

5Pre-Enrichment for Detection of Borrelia, Babesia, Bartonella and Mycoplasma
CategoryMolecular Diagnostic Service
Description

Enrichment media service that increases copy number of specific pathogens (Borrelia, Babesia, Bartonella, and Mycoplasma species) prior to PCR detection, with a 10-day incubation period to improve sensitivity for low-copy pathogens; charged at $125 per organism in addition to PCR testing.

6LAL Bacterial Endotoxin Testing
CategoryContract Research / GLP Testing Service
Description

Limulus Amoebocyte Lysate (LAL) kinetic chromogenic assay for bacterial endotoxin detection using Associates of Cape Cod reagents, offered in GLP ($325/sample, 2–5 day turnaround, Protocol CB129) and non-GLP ($225/sample, Protocol CB130) formats for pharmaceutical and biotech clients.

7Mycoplasma Testing in Biologicals
CategoryContract Research / GLP Testing Service
Description

Comprehensive mycoplasma testing for biologicals including Hoechst staining, multiplex PCR, direct cultivation, and GLP-compliant testing per 21CFR 610.30 and 9CFR 113.28; also offers mycoplasma elimination services for contaminated cell lines (e.g., Mycoplasma Testing by Multiplex PCR Non-GLP at $109/sample, 1–3 day turnaround).

8In Vitro Studies
CategoryContract Research Service
Description

Custom in vitro studies for biotech and biopharmaceutical clients, including drug screening against viral agents in cell culture and molecular assay design.

9Clinical Trial Support
CategoryContract Research Service
Description

Assistance with clinical trials including evaluation of investigational drugs in vitro, vaccine testing, assay optimization, molecular cloning, protein expression, toxicology assays, and immunoassays under GLP/cGMP guidelines for pharmaceutical and biotech sponsors.

10Lyme Tick Panel
CategoryClinical Diagnostic Service / Tick-Borne Disease Testing
Description

Highly sensitive real-time PCR test panel for the most common tick-borne infections including Borrelia species, Babesia species, Bartonella species, and Mycoplasma species; intended for clinicians and patients suspecting tick exposure or Lyme disease.

11Zika, Dengue and Chikungunya Virus Detection
CategoryClinical Diagnostic Service / Virology
Description

Real-time PCR-based molecular detection of Zika, Dengue, and Chikungunya virus RNA in human specimens; offered to clinicians and public health testing during outbreak response.

Scale indicator10 records

Each record includes

Type, Value, Description, Source

Recent move8 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
TypeBroad incumbent
Description

Major academic reference laboratory with extensive molecular infectious disease menu, used by hospitals and clinicians nationwide. Same broad positioning as Clongen but with substantially deeper test catalog and global reach.

TypeBroad incumbent
Description

National reference lab offering molecular infectious disease testing, including tick-borne and STD panels. Competes on the same clinical diagnostics menu as Clongen but with national logistics, broad payer contracts, and significantly larger scale.

TypeDirect peer
Description

Specialty PCR-based infectious disease and STI molecular diagnostics reference lab serving clinicians and hospitals. Comparable scale and go-to-market to Clongen's Clinical Diagnostics Services division, with similar assay menu emphasis.

TypeBroad incumbent
Description

National clinical reference laboratory with a broad molecular diagnostics and infectious disease menu, plus biopharma central lab services through its drug development arm. Comparable clinical and CRO offerings to Clongen at much larger scale.

TypeDirect peer
Description

Specialty infectious disease and immunocompromised molecular diagnostics lab offering PCR-based pathogen detection and biopharma testing services. Directly overlaps Clongen's clinical molecular diagnostics and contract research menus (real-time PCR, mycoplasma, viral load testing).

TypeBroad incumbent
Description

Large academic reference lab offering 3,000+ tests including molecular infectious disease and esoteric assays. Comparable menu coverage to Clongen but at vastly greater scale, multi-state licensure, and biopharma trial support.

TypeBroad incumbent
Description

Global CRO offering biologics safety testing including mycoplasma, sterility, and endotoxin (LAL) services under GLP. Direct overlap with Clongen's Contract Research Services division serving biopharma lot release, but at much greater scale and global footprint.

TypeBroad incumbent
Description

Global CRO providing biologics safety testing including mycoplasma, viral clearance, sterility, and endotoxin services for biopharma lot release. Comparable GLP testing menu to Clongen's Contract Research Services but at global scale across multiple continents.

TypeBroad incumbent
Description

Global bioanalytical and clinical testing network with significant presence in infectious disease molecular diagnostics, biopharma release testing, and veterinary diagnostics. Comparable three-vertical structure to Clongen (clinical/contract research/vet) at vastly larger scale.

10IGeneX
TypeDirect peer
Description

Specialty reference laboratory focused on tick-borne disease testing (Lyme, Babesia, Bartonella, etc.) using PCR and immunoassay. Closest comparable to Clongen's Lyme Tick Panel and Pre-Enrichment workflow; both serve clinicians seeking esoteric tick-borne diagnostics.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat4 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Segment5 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature4 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles3 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

Subsidiaries1 record

Each record includes

Name, Acquired on, Relationship type, Type, Business focus

Compliance8 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Clongen Laboratories

Molecular Diagnostics / Clinical Laboratory Servicesclongen.com

Clongen Laboratories is a CLIA-certified, CAP-accredited specialty molecular diagnostics lab in Gaithersburg, MD offering 240+ PCR-based tests for clinicians, hospitals, reference labs, biotech CROs, and veterinarians, with a specialty focus on tick-borne and other infectious diseases.

What Clongen Laboratories does

Clongen Laboratories, LLC is a privately held, founder-led specialty molecular diagnostics laboratory headquartered in Gaithersburg, Maryland. Founded in 1999 by Dr. Ahmed Kilani, the company operates a 6,000 square-foot CLIA-certified, CAP-accredited facility holding two FDA registrations and clinical laboratory licenses in Maryland, Rhode Island, Pennsylvania, and California. Its core technology is real-time and conventional PCR applied to detection of infectious agents, supplemented by proprietary methods including a Mycoplasma Multiplex PCR Detection Kit (MycoFind) and a pre-enrichment protocol for low-copy tick-borne pathogens such as Borrelia, Babesia, Bartonella, and Mycoplasma species.

The business is organized into three service lines: Clinical Diagnostics Services (240+ molecular assays for clinicians, hospitals, and reference clinical laboratories, with a specialty in tick-borne illness and Lyme disease), Contract Research Services (GLP-compliant lot release and FDA review studies, including sterility testing, LAL bacterial endotoxin testing, mycoplasma testing in biologicals, and clinical trial support for pharma and biotech), and Veterinary Diagnostic Services (100+ assays covering companion animals, livestock, primates, rodents, birds, amphibians, and reptiles). Pricing is quote-based with some published unit prices (e.g., MycoFind kit at $250, LAL GLP at $325 per sample, Mycoplasma PCR at $109 per sample); the company advertises pricing at least 10% below competitors and offers volume discounts.

The go-to-market is sales-led, relying on a direct team reaching clinicians, hospitals, and clinical labs primarily through the company website, PR Newswire releases, toll-free phone (877-CLONGEN), and quote forms. Distribution is exclusively direct; samples are shipped to the Gaithersburg lab. The company is unrelated in name to any other entity and is owned by its founder. A sister company, Clongen Pharma, LLC, is announced for launch in March 2026 to develop cancer therapeutics — a separate entity outside Clongen Laboratories' diagnostic scope. Clongen does not disclose revenue and has no external funding rounds on record.

Clongen Laboratories firmographics

Firmographics
Name
Clongen Laboratories
Legal name
Clongen Laboratories, LLC
Website
https://clongen.com
Company type
Private
Founded year
1999
Operating status
Operating
Headcount range
1–10 employees
Short description
Clongen Laboratories is a CLIA-certified, CAP-accredited specialty molecular diagnostics lab in Gaithersburg, MD offering 240+ PCR-based tests for clinicians, hospitals, reference labs, biotech CROs, and veterinarians, with a specialty focus on tick-borne and other infectious diseases.
Ownership category
akta.pro rank

Clongen Laboratories industry classification

Industry
Product category
Molecular Diagnostics / Clinical Laboratory Services
NAICS
Medical Laboratories (621511), In-Vitro Diagnostic Substance Manufacturing (325413)
SIC
Services-Medical Laboratories (8071), Services-Commercial Physical & Biological Research (8731)
akta.pro industry
PRIMARYHLAGAAAE
Central Laboratory & Clinical Trial Testing CROs
SECONDARYHLAGADAC
Release Testing & Batch Certification (QC)

Keywords

  • Molecular diagnostics services
  • Contract research organization
  • Clinical laboratory testing
  • PCR detection assays
  • Veterinary diagnostic services

Where Clongen Laboratories is headquartered

Location

Headquarters

HQ city
Gaithersburg
HQ country
United States
HQ region
North America

Offices1 record

Markets served

Clongen Laboratories business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Personnel, Operations, Technology or R&D, Infrastructure, Supply Chain, Marketing or Sales

Revenue model

  1. Clinical Diagnostic Testing Services: Molecular-based assays for detection of common pathogens (bacteria, viruses, fungi, and parasites) offered to clinicians, hospitals, and clinical laboratories. Includes tick testing, STD tests, bloodborne pathogen tests, and over 200 assays for infectious disease detection.
  2. Contract Research Services: GLP-compliant studies required for lot release and FDA review for pharmaceutical companies, biotech firms, and research institutions. Includes sterility testing, LAL bacterial endotoxin testing, Mycoplasma testing in biologicals, and custom molecular and cell biology services.
  3. Veterinary Diagnostic Services: Over 100 assays to identify diseases or cause of death in animals including dogs, cats, horses, livestock, primates, rodents, birds, amphibians, and reptiles.
  4. Test Kit Sales: Sale of MycoFind Mycoplasma PCR Detection Kit (catalog number MF001, Version 1.0) priced at $250.00 per unit for 100 reactions. Ships with overnight ice packs.

Pricing tiers

ModelBillingPrice
Unit PricingPay-as-you-goMycoFind Mycoplasma PCR Detection Kit – $250.00
Unit PricingPay-as-you-goPre-Enrichment per organism – $125
Unit PricingPay-as-you-goLAL Endotoxin Testing GLP – $325 per sample
Unit PricingPay-as-you-goLAL Endotoxin Testing Non-GLP – $225 per sample
Unit PricingPay-as-you-goMycoplasma Testing by Multiplex PCR (Non-GLP) – $109
Unit PricingPay-as-you-goCandida tropicalis – $200

Go-to-market motion1 record

Distribution channels1 record

Marketing channels4 records

Clongen Laboratories product offering

Product offering

Core offering

Clongen Laboratories is a CLIA-certified, CAP-accredited clinical molecular diagnostics laboratory that performs PCR-based testing for infectious agents in human and animal specimens. The company operates three service divisions: Clinical Diagnostics Services (200+ molecular assays), Contract Research Services (GLP-compliant lot release, sterility, LAL endotoxin, and mycoplasma testing for pharma/biotech), and Veterinary Diagnostic Services (100+ assays across many species), and also sells the MycoFind Mycoplasma PCR Detection Kit as a research product.

Product overview

Clongen Laboratories is a molecular diagnostics laboratory offering three core divisions: Clinical Diagnostics Services, Contract Research Services, and Veterinary Diagnostic Services. The company provides more than 240 molecular-based PCR tests for detection of human pathogens (bacteria, viruses, fungi, parasites), with special expertise in tick-borne illnesses and Lyme disease. For contract research, the company offers GLP-compliant lot release testing including sterility testing, bacterial endotoxin testing (LAL), mycoplasma testing, and mycoplasma elimination services. The company also manufactures the MycoFind™ Mycoplasma PCR Detection Kit as a research use product. All services operate under CLIA certification and CAP accreditation with state licenses in multiple states.

Differentiator

Problem solved

Functional benefit

Brands

  • MycoFind: Mycoplasma Multiplex PCR Detection Kit - a test kit product line for detection of Mycoplasma, Acholeplasma and Ureaplasma species in cell cultures
  • Clongen Clinical Laboratory

Products and services

  • Clinical Diagnostics Services CLIA-certified clinical laboratory offering more than 200 molecular-based PCR assays for detection of bacteria, viruses, fungi, and parasites, with specialty in tick-borne illnesses (including Lyme disease), STD testing, bloodborne pathogen testing, pulmonary disease testing, parasitology, mycology, and virology; serves clinicians, hospitals, and clinical laboratories submitting patient specimens.
  • Contract Research Services FDA-compliant contract research organization providing GLP-compliant lot release testing, sterility testing, mycoplasma testing in biologicals per 21CFR 610.30 and 9CFR 113.28, LAL bacterial endotoxin testing, custom molecular and cell biology services, and clinical trial support for pharmaceutical, biotech, and research institution clients.
  • Veterinary Diagnostic Services Veterinary diagnostic testing division offering more than 100 molecular assays to identify diseases or determine cause of death across a broad range of animal species including dogs, cats, horses, livestock, primates, rodents, birds, amphibians, and reptiles; serves veterinarians and animal health professionals.
  • MycoFind™ Mycoplasma PCR Detection Kit Multiplex PCR detection kit (Catalog MF001, Version 1.0) for amplification of a conserved region of 16S ribosomal DNA of more than 25 Mycoplasma, Acholeplasma, and Ureaplasma species; sold as a research-use product with overnight ice-pack shipping (taq DNA polymerase supplied by user).
  • Pre-Enrichment for Detection of Borrelia, Babesia, Bartonella and Mycoplasma Enrichment media service that increases copy number of specific pathogens (Borrelia, Babesia, Bartonella, and Mycoplasma species) prior to PCR detection, with a 10-day incubation period to improve sensitivity for low-copy pathogens; charged at $125 per organism in addition to PCR testing.
  • LAL Bacterial Endotoxin Testing Limulus Amoebocyte Lysate (LAL) kinetic chromogenic assay for bacterial endotoxin detection using Associates of Cape Cod reagents, offered in GLP ($325/sample, 2–5 day turnaround, Protocol CB129) and non-GLP ($225/sample, Protocol CB130) formats for pharmaceutical and biotech clients.
  • Mycoplasma Testing in Biologicals Comprehensive mycoplasma testing for biologicals including Hoechst staining, multiplex PCR, direct cultivation, and GLP-compliant testing per 21CFR 610.30 and 9CFR 113.28; also offers mycoplasma elimination services for contaminated cell lines (e.g., Mycoplasma Testing by Multiplex PCR Non-GLP at $109/sample, 1–3 day turnaround).
  • In Vitro Studies Custom in vitro studies for biotech and biopharmaceutical clients, including drug screening against viral agents in cell culture and molecular assay design.
  • Clinical Trial Support Assistance with clinical trials including evaluation of investigational drugs in vitro, vaccine testing, assay optimization, molecular cloning, protein expression, toxicology assays, and immunoassays under GLP/cGMP guidelines for pharmaceutical and biotech sponsors.
  • Lyme Tick Panel Highly sensitive real-time PCR test panel for the most common tick-borne infections including Borrelia species, Babesia species, Bartonella species, and Mycoplasma species; intended for clinicians and patients suspecting tick exposure or Lyme disease.
  • Zika, Dengue and Chikungunya Virus Detection Real-time PCR-based molecular detection of Zika, Dengue, and Chikungunya virus RNA in human specimens; offered to clinicians and public health testing during outbreak response.

Companies that use Clongen Laboratories

Customer profile

Segments5 records

Ideal customer profiles3 records

Clongen Laboratories technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature4 records

Clongen Laboratories partnerships and signals

Strategic signal

Scale indicators10 records

Recent moves8 records

Expansion highlights5 records

Clongen Laboratories competitors and assessment

Company assessment

Broad incumbents

  • Mayo Clinic Laboratories: Major academic reference laboratory with extensive molecular infectious disease menu, used by hospitals and clinicians nationwide. Same broad positioning as Clongen but with substantially deeper test catalog and global reach.
  • Quest Diagnostics: National reference lab offering molecular infectious disease testing, including tick-borne and STD panels. Competes on the same clinical diagnostics menu as Clongen but with national logistics, broad payer contracts, and significantly larger scale.
  • Laboratory Corporation of America (Labcorp): National clinical reference laboratory with a broad molecular diagnostics and infectious disease menu, plus biopharma central lab services through its drug development arm. Comparable clinical and CRO offerings to Clongen at much larger scale.
  • ARUP Laboratories: Large academic reference lab offering 3,000+ tests including molecular infectious disease and esoteric assays. Comparable menu coverage to Clongen but at vastly greater scale, multi-state licensure, and biopharma trial support.
  • Charles River Laboratories: Global CRO offering biologics safety testing including mycoplasma, sterility, and endotoxin (LAL) services under GLP. Direct overlap with Clongen's Contract Research Services division serving biopharma lot release, but at much greater scale and global footprint.
  • WuXi AppTec: Global CRO providing biologics safety testing including mycoplasma, viral clearance, sterility, and endotoxin services for biopharma lot release. Comparable GLP testing menu to Clongen's Contract Research Services but at global scale across multiple continents.
  • Eurofins Scientific: Global bioanalytical and clinical testing network with significant presence in infectious disease molecular diagnostics, biopharma release testing, and veterinary diagnostics. Comparable three-vertical structure to Clongen (clinical/contract research/vet) at vastly larger scale.

Direct peers

  • Molecular Testing Labs: Specialty PCR-based infectious disease and STI molecular diagnostics reference lab serving clinicians and hospitals. Comparable scale and go-to-market to Clongen's Clinical Diagnostics Services division, with similar assay menu emphasis.
  • Eurofins Viracor BioPharma Services: Specialty infectious disease and immunocompromised molecular diagnostics lab offering PCR-based pathogen detection and biopharma testing services. Directly overlaps Clongen's clinical molecular diagnostics and contract research menus (real-time PCR, mycoplasma, viral load testing).
  • IGeneX: Specialty reference laboratory focused on tick-borne disease testing (Lyme, Babesia, Bartonella, etc.) using PCR and immunoassay. Closest comparable to Clongen's Lyme Tick Panel and Pre-Enrichment workflow; both serve clinicians seeking esoteric tick-borne diagnostics.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights7 records

Customer concentration

Clongen Laboratories social profiles

Digital presence

Clongen Laboratories compliance and trust

Trust signal

Compliance8 records

Clongen Laboratories financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Clongen Laboratories leadership team

Management profile

Number of profiles

Profiles3 records

Clongen Laboratories subsidiaries and ownership

Company hierarchy

Subsidiaries1 record

Clongen Laboratories funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Clongen Laboratories M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Clongen Laboratories

What does Clongen Laboratories do?

Clongen Laboratories is a CLIA-certified, CAP-accredited clinical molecular diagnostics laboratory that performs PCR-based testing for infectious agents in human and animal specimens. The company operates three service divisions: Clinical Diagnostics Services (200+ molecular assays), Contract Research Services (GLP-compliant lot release, sterility, LAL endotoxin, and mycoplasma testing for pharma/biotech), and Veterinary Diagnostic Services (100+ assays across many species), and also sells the MycoFind Mycoplasma PCR Detection Kit as a research product.

Is Clongen Laboratories a public or private company?

Clongen Laboratories is a private company. It is classified as founder individual operated bootstrapped and is currently operating.

When was Clongen Laboratories founded?

Clongen Laboratories was founded in 1999. It employs 1 to 10 people.

Where is Clongen Laboratories based?

Clongen Laboratories is headquartered in Gaithersburg, United States, in the North America region.

How does Clongen Laboratories make money?

Four revenue lines are on record. Clinical Diagnostic Testing Services are the primary driver. The others are contract Research Services, veterinary Diagnostic Services and test Kit Sales.

Who are Clongen Laboratories's main competitors?

Broad incumbents on record are Mayo Clinic Laboratories, Quest Diagnostics, Laboratory Corporation of America (Labcorp), ARUP Laboratories, Charles River Laboratories, WuXi AppTec and Eurofins Scientific. Direct peers are Molecular Testing Labs, Eurofins Viracor BioPharma Services and IGeneX.

Does Clongen Laboratories have an API?

No public API is recorded for Clongen Laboratories.

What industry is Clongen Laboratories in?

Clongen Laboratories's product category is Molecular Diagnostics / Clinical Laboratory Services. Its primary akta.pro industry code is HLAGAAAE, Central Laboratory & Clinical Trial Testing CROs, with a secondary code of HLAGADAC, Release Testing & Batch Certification (QC). Its NAICS code is 621511 and its SIC code is 8071.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
PR NewswireClongen Laboratories, LLC Announces Launch of Sister Company Clongen Pharma, LLC in March 2026Clongen Laboratories, LLC announced the launch of a new sister company, Clongen Pharma, LLC, planned for March 2026, which will focus on developing novel, targeted cancer therapeutics for blood cancers and solid tumors. The new entity will be headquartered in Gaithersburg, Maryland, and the company plans to recruit scientists with expertise in cancer biology and engage with academic institutions for potential partnerships and investments. Clongen Laboratories, founded in 2004 and currently operating as a CAP-accredited molecular diagnostics and contract research services provider, is establishing the new company as a strategic direction to complement its existing services and address health challenges.MorningstarClongen Laboratories, LLC Announces Launch of Sister Company Clongen Pharma, LLC in March 2026Clongen Laboratories, LLC announced plans to launch sister company Clongen Pharma, LLC in March 2026, focusing on developing targeted cancer therapeutics. The new company will be headquartered in Gaithersburg, MD, and will recruit scientists with expertise in cancer biology. Further details, including the company website launch, will be provided in future updates.PR NewswireClongen Laboratories, LLC receive CAP accreditationClongen Laboratories, LLC received accreditation from the College of American Pathologists (CAP), a globally recognized program for clinical laboratory excellence. This milestone reaffirms the company's commitment to quality standards alongside its existing CLIA certification and state licenses. The accreditation highlights Clongen's capabilities in molecular diagnostics and contract research services.PR NewswireClongen Laboratories, LLC to offer Zika, Dengue and Chikungunya virus molecular detectionClongen Laboratories announced it is now offering molecular detection tests for Zika, Dengue, and Chikungunya viruses, leveraging highly specific genomic detection methods that avoid the cross-reactivity issues common with serology tests. The company, headquartered in Gaithersburg, Maryland, is positioning this launch as part of its long-term strategy to stay ahead of emerging pathogens using cutting-edge diagnostic technologies. The timing coincides with WHO estimates that 3 to 4 million people will contract Zika virus worldwide in the next 12 months, with infections now reported in 61 countries and territories since 2007.